This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the article, Torrey reviews the history of the Human Genome Project, their hopes for identifying the genetic basis for schizophrenia, and how those hopes have been dashed by the complete failure to find anything of the sort. Fuller Torrey. Nor have any new treatments become available from this research.”
Moreover, in stark contrast to the discoveries by medical researchers of biological causation for many physical illnesses, psychiatric researchers have failed to find physiological or genetic causation for the most diagnosed mental disorders—the anxiety disorders and depression—negating the rationale for the prescription of these drugs.
A fter years of work involving hundreds of people in dozens of countries, the World Health Organisation (WHO) and the United Nations Office of the High Commissioner for Human Rights (OHCHR) have released their joint production, MentalHealth, Human Rights and Legislation: Guidance and Practice ( WHO/OHCHR , 2023, referred to as the Guidance.
The prevailing logic goes: if we can validate biometric tests that are clinically predictive of mentalhealth concerns like in other medical fields, we can more precisely, effectively, and without (solely) subjective clinical observation, treat the malady. Should we give up the search for biomarkers altogether?
While the exact cause is still not clear, most experts point to a combination of genetics, brain chemistry and structure, and environment. Stressful events like trauma and substance abuse can trigger onset of or make symptoms worse in people who might be vulnerable. How Common is Schizoaffective Disorder? How is it Diagnosed?
His work spans everything from the cultural history of mental illness to mindfulness, death anxiety, and resiliencenot the hollow kind that comes from pretending everythings fine, but the kind that comes from staring into the void and refusing to flinch. Hes a professor of psychology and the director of the Psy.D. He earned his Ph.D.
Editor’s Note: Mad in the UK and Mad in America are jointly publishing this four-part series on neurodiversity. The series was edited by Mad in the UK editors, and authored by John Cromby and Lucy Johnstone (with part three written by an anonymous contributor). The series is being archived here.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content